| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |